Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids()()

por Sharbeen, G., McCarroll, J., Liu, J., Youkhana, J., Limbri, L.F., Biankin, A.V., Johns, A., Kavallaris, M., Goldstein, D., Phillips, P.A.
Publicado 2016

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine

por Casolino, R., Braconi, C., Malleo, G., Paiella, S., Bassi, C., Milella, M., Dreyer, S.B., Froeling, F.E.M., Chang, D.K., Biankin, A.V., Golan, T.
Publicado 2021

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing

por Paiella, S., Azzolina, D., Gregori, D., Malleo, G., Golan, T., Simeone, D.M., Davis, M.B., Vacca, P.G., Crovetto, A., Bassi, C., Salvia, R., Biankin, A.V., Casolino, R.
Publicado 2023

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

por Millar, E K A, Anderson, L R, McNeil, C M, O'Toole, S A, Pinese, M, Crea, P, Morey, A L, Biankin, A V, Henshall, S M, Musgrove, E A, Sutherland, R L, Butt, A J
Publicado 2009

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma

por Murphy, N C, Scarlett, C J, Kench, J G, Sum, E Y M, Segara, D, Colvin, E K, Susanto, J, Cosman, P H, Lee, C-S, Musgrove, E A, Sutherland, R L, Lindeman, G J, Henshall, S M, Visvader, J E, Biankin, A V
Publicado 2008

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer

por Harris, N L E, Vennin, C, Conway, J R W, Vine, K L, Pinese, M, Cowley, M J, Shearer, R F, Lucas, M C, Herrmann, D, Allam, A H, Pajic, M, Morton, J P, Biankin, A V, Ranson, M, Timpson, P, Saunders, D N
Publicado 2017

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

por Humphris, J. L., Chang, D. K., Johns, A. L., Scarlett, C. J., Pajic, M., Jones, M. D., Colvin, E. K., Nagrial, A., Chin, V. T., Chantrill, L. A., Samra, J. S., Gill, A. J., Kench, J. G., Merrett, N. D., Das, A., Musgrove, E. A., Sutherland, R. L., Biankin, A. V.
Publicado 2012

Adjuvant chemotherapy in elderly patients with pancreatic cancer

por Nagrial, A M, Chang, D K, Nguyen, N Q, Johns, A L, Chantrill, L A, Humphris, J L, Chin, V T, Samra, J S, Gill, A J, Pajic, M, Pinese, M, Colvin, E K, Scarlett, C J, Chou, A, Kench, J G, Sutherland, R L, Horvath, L G, Biankin, A V
Publicado 2014

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

por Veenstra, V. L., Damhofer, H., Waasdorp, C., van Rijssen, L. B., van de Vijver, M. J., Dijk, F., Wilmink, H. W., Besselink, M. G., Busch, O. R., Chang, D. K., Bailey, P. J., Biankin, A. V., Kocher, H. M., Medema, J. P., Li, J. S., Jiang, R., Pierce, D. W., van Laarhoven, H. W. M., Bijlsma, M. F.
Publicado 2018